Watchlist Price Alert

Gilead Sciences Inc. (GILD)

NASDAQ: GILD · Real-Time Price · USD

106.98

-1.52 (-1.40%)

At close: Jun 23, 2025, 10:15 AM

Gilead Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	9.99B	6.08B	5.41B	5.34B	6B	11.63B	17.94B	7.59B	8.23B
Short-Term Investments	1.58B	1.18B	973M	1.18B	1.41B	12.72B	12.15B	17.92B	3.67B
Long-Term Investments	n/a	1.16B	1.25B	1.31B	502M	1.49B	1.42B	11.18B	20.48B
Other Long-Term Assets	6.15B	4.79B	4.8B	4.96B	5.71B	7.44B	2.56B	2.72B	3.49B
Receivables	4.42B	4.66B	4.78B	4.49B	4.89B	3.58B	3.33B	3.85B	4.51B
Inventory	1.71B	1.79B	1.51B	1.62B	1.68B	922M	814M	801M	1.59B
Other Current Assets	995M	2.37B	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	19.17B	16.09B	14.44B	14.77B	16B	30.3B	35.84B	31.82B	19.59B
Property-Plant & Equipment	5.41B	5.32B	5.47B	5.12B	4.97B	4.5B	4.01B	3.29B	2.87B
Goodwill & Intangibles	28.26B	34.77B	37.21B	41.79B	41.23B	17.9B	19.86B	21.26B	10.14B
Total Long-Term Assets	39.82B	46.04B	48.73B	53.18B	52.41B	31.33B	27.84B	38.46B	37.39B
Total Assets	58.99B	62.13B	63.17B	67.95B	68.41B	61.63B	63.67B	70.28B	56.98B
Account Payables	833M	550M	905M	705M	844M	713M	790M	814M	1.21B
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	202M
Short-Term Debt	1.81B	1.8B	2.27B	1.52B	2.76B	2.5B	2.75B	2.75B	n/a
Other Current Liabilities	3.82B	3.92B	3.62B	1.43B	1.45B	736M	555M	455M	196M
Total Current Liabilities	12B	11.28B	11.24B	11.61B	11.4B	9.76B	10.61B	11.63B	9.22B
Long-Term Debt	24.9B	23.19B	22.96B	25.18B	28.64B	22.09B	24.57B	30.8B	26.35B
Other Long-Term Liabilities	2.13B	4.36B	5.09B	5.74B	6.23B	7.12B	6.96B	7.35B	2.05B
Total Long-Term Liabilities	27.75B	28.1B	30.72B	35.28B	38.79B	29.22B	31.54B	38.15B	28.4B
Total Liabilities	39.75B	39.38B	41.96B	46.89B	50.19B	38.98B	42.14B	49.78B	37.61B
Total Debt	26.71B	24.99B	25.23B	26.7B	31.4B	24.59B	27.32B	33.54B	26.35B
Common Stock	1M	1M	1M	1M	1M	1M	1M	1M	1M
Retained Earnings	11.5B	16.3B	15.69B	16.32B	14.38B	19.39B	19.02B	19.01B	18.15B
Comprehensive Income	132M	28M	2M	83M	-60M	85M	80M	165M	278M
Shareholders Equity	19.33B	22.83B	21.24B	21.07B	18.2B	22.52B	21.39B	20.44B	18.89B
Total Investments	1.58B	2.34B	2.22B	2.49B	1.91B	14.21B	13.57B	29.11B	24.15B